Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · IEX Real-Time Price · USD
7.50
-0.05 (-0.66%)
At close: Apr 19, 2024, 4:00 PM
7.45
-0.05 (-0.67%)
After-hours: Apr 19, 2024, 7:12 PM EDT

Voyager Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current202320222021202020192018201720162015
Market Capitalization
407371236103268517306447340586
Market Cap Growth
-57.67%128.95%-61.60%-48.20%68.99%-31.59%31.42%-41.89%-
Enterprise Value
176140117-3087236150278166391
PE Ratio
2.532.81-5.07-1.447.29-11.86-3.47-6.33-8.47-15.30
PS Ratio
1.631.495.762.751.574.9540.1744.1423.9433.80
PB Ratio
1.721.573.991.081.745.206.593.342.503.47
P/FCF Ratio
5.454.97-15.70-1.87-2.4612.58-15.16-6.85-7.1614.55
P/OCF Ratio
5.234.77-18.83-1.92-2.7710.63-19.26-7.29-8.0114.18
EV/Sales Ratio
0.710.562.85-0.790.512.2619.7227.4611.6722.58
EV/EBITDA Ratio
1.391.11-2.780.452.23-4.98-1.74-4.03-4.20-13.47
EV/EBIT Ratio
1.451.15-2.420.422.47-4.71-1.70-3.94-4.14-13.19
EV/FCF Ratio
2.361.88-7.780.54-0.805.73-7.44-4.26-3.499.72
Quick Ratio
4.874.871.642.617.073.954.9210.6312.648.12
Current Ratio
4.964.961.722.687.394.015.1310.8112.958.19
Asset Turnover
0.770.770.220.180.600.270.040.060.070.14
Interest Coverage
----181.56------
Return on Equity (ROE)
63.90%63.90%-67.50%-66.30%30.80%-40.90%-120.80%-63.20%-26.60%-51.70%
Return on Assets (ROA)
40.80%40.80%-24.60%-34.50%12.80%-11.40%-42.90%-42.90%-19.60%-31.80%
Return on Capital (ROIC)
51.09%51.09%-86.14%-77.45%17.74%-51.93%-196.13%-53.61%-30.38%-11.98%
Earnings Yield
32.49%35.64%-19.71%-69.21%13.72%-8.43%-28.85%-15.80%-11.81%-6.54%
FCF Yield
18.33%20.11%-6.37%-53.60%-40.62%7.95%-6.60%-14.60%-13.96%6.87%
Buyback Yield / Dilution
-16.20%-16.20%-1.83%-0.86%-4.04%-11.95%-19.63%-5.93%-503.70%-559.57%
Total Shareholder Return
-16.20%-16.20%-1.83%-0.86%-4.04%-11.95%-19.63%-5.93%-503.70%-559.57%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).